AI Investment Decisions in Life Sciences with Daniel Buchta from Lonza

AI Investment Decisions in Life Sciences A curated executive roundtable in Basel, with guest of honour Daniel Buchta, Head of Investor Relations, Lonza.

⚠️ Important: registration happens on Luma, not on Meetup. An RSVP here does not reserve a seat. To request your place, register at: 👉 https://luma.com/l09kirf4

About the evening A private, off-the-record exchange among senior leaders from pharma, biotech and medtech on how AI investment decisions are actually made at the executive level.

The question on the table If you had to justify a major AI investment today, how would you frame the decision? We will look at strategic priorities, risk, and the choice to build, buy or partner, including investing directly in the AI startup ecosystem. What does that mean inside a regulated industry, and which models suit R&D, Commercial Ops or Tech Ops?

Who is at the table CEOs and C-level executives (CTO, CIO, CDO), VPs and board members from leading life sciences companies across Switzerland.

Why register on Luma The table is deliberately small: 8 to 12 participants. It is a ticketed event, and every registration is reviewed and validated so the conversation stays candid and meaningful for everyone who takes part. Luma is where we handle tickets, approvals and the venue details.

When: Monday, 26 October 2026, 18:00 – 19:30
Where: A central venue in Basel Stadt, such as a leading hotel. The exact address is sent by email once your registration is confirmed.
A light aperitivo with a selection of finger food will be served during the evening.

Register here: https://luma.com/l09kirf4
Questions: [info@techlounges.com](mailto:info@techlounges.com)
Organized by TechLounges Association, Basel.